#85 - Pride, peptides, & pioneering pregnancies

The coffee break biotech roundup, by SomX.

Feb 28 • Daisy Makin and Belle Taylor

3

#84 - Overpriced primates, shocks for selfishness & death delayed

The coffee break biotech roundup, by SomX.

Feb 21 • Andrew, Daisy Makin, and Belle Taylor

#83 - Tumour terrain, T-cell turns, & trailblazing women

The coffee break biotech roundup, by SomX.

Feb 14 • Daisy Makin and Jessica Smith

2

#82 - Facial firsts, follicle fixes & period-powered cancer probes

The coffee break biotech roundup, by SomX.

Feb 7 • Andrew and Daisy Makin

2

January 2026

#81- Synthetic viruses, shady CEOs, & sinusitis saviours

The coffee break biotech roundup, by SomX.

Jan 31 • Daisy Makin and Belle Taylor

5

1

#80- Boozy bacteria, anti-ageing vaccines, & predicting dementia

The coffee break biotech roundup, by SomX.

Jan 24 • Andrew, Daisy Makin, and Belle Taylor

4

1

#79- Platforms, patients & pipelines at JPM

The coffee break biotech roundup, by SomX.

Jan 17 • Daisy Makin and Belle Taylor

4

1

#78 - Sleep prophecies, clinical conjuring, & corporate clairvoyance

The coffee break biotech roundup, by SomX.

Jan 10 • Andrew, Belle Taylor, and Daisy Makin

4

December 2025

#77 - Yuletide isotopes, venture stockings, & the hunger helper

The coffee break biotech roundup, by SomX.

Dec 20, 2025 • Daisy Makin and Belle Taylor

4

2

#76 - Fungal fowl, fertility failings & Parkinsons in our pipes

The coffee break biotech roundup, by SomX.

Dec 13, 2025 • Andrew, Daisy Makin, and Belle Taylor

1

1

#75 – Policy shifts, GLP plateaus, & pattern baldness

The coffee break biotech roundup, by SomX.

Dec 8, 2025 • Daisy Makin and Jessica Smith

1

November 2025

#74 - Enzymes, espionage, and experimental excrement

The coffee break biotech roundup, by SomX.

Nov 29, 2025 • Andrew and Daisy Makin

3